Health
GSK’s blood cancer drug hits major target in late-stage trial
GSK said on Monday that its blood cancer drug Blenrep has hit a key late-stage trial target, potentially boosting the British drugmaker’s oncology division after
Japan has discovered its first bird flu case of the season, killing
Japan has detected the season’s first highly pathogenic H5-type bird flu at a poultry farm in the south of the country, public broadcaster NHK reported
Zimbabwe restricts gatherings as cholera cases surge
Zimbabwe’s government has begun restricting public gatherings and the sale of food after a spike in cholera cases. New cholera cases in the southern African
Novo to launch Wegovy in Japan on 22 February
Novo Nordisk will launch its popular anti-obesity drug Wegovy in Japan on 22 February, its first launch in Asia. The Danish company has chosen Japan
Scientists warn against panic after report on pneumonia in China
Leading scientists urged caution amid fears of another pandemic after the World Health Organisation requested more information from China on a rise in respiratory illnesses
Novo Nordisk to invest $2.3m in France to boost production
Danish drugmaker Novo Nordisk said on Thursday it will invest more than 16 billion crowns ($2.34 billion) to expand its manufacturing capacity at Chartres in
WHO requested detailed information from China on respiratory disease outbreaks
The World Health Organisation has asked China for details on the rise in respiratory diseases and reported clusters of pneumonia in children in what its
Indonesian documents reveal events leading to cough syrup deaths
Indonesian court documents have for the first time revealed the chain of events that led to the use of toxic ingredients in cough syrup, one
The European Patent Office has invalidated Moderna’s mRNA patent
The European Patent Office has invalidated a contested mRNA patent owned by Moderna, the office said Tuesday, handing a victory to BioNTech and its partner
Texas AG sues Pfizer over quality control violations for paediatric ADHD drug
Texas Attorney General Ken Paxton accused Pfizer and its supplier Tris Pharma of providing children’s ADHD medications they knew might be ineffective for the state’s